Ambee Pharmaceuticals PLC (DSE:AMBEEPHA)

Bangladesh flag Bangladesh · Delayed Price · Currency is BDT
763.10
-5.10 (-0.66%)
At close: Mar 2, 2026
4.95%
Market Cap 1.83B
Revenue (ttm) 193.90M
Net Income (ttm) 4.82M
Shares Out 2.40M
EPS (ttm) 2.01
PE Ratio 379.94
Forward PE n/a
Dividend 1.00 (0.13%)
Ex-Dividend Date Nov 23, 2025
Volume 583
Average Volume 1,742
Open n/a
Previous Close 768.20
Day's Range 762.00 - 777.70
52-Week Range 681.00 - 947.90
Beta -0.39
RSI 64.77
Earnings Date Apr 23, 2026

About Ambee Pharmaceuticals

Ambee Pharmaceuticals PLC engages in the manufacture, buy, sell, export, or deal in drugs, medicines, pharmaceuticals, chemicals, medical, and other preparations in Bangladesh. The company offers tablets, capsules, liquids, gel in tubes, and injectables for therapeutic areas, such as antiulcerant, antacid, antibacterial, antifungal, anti-protozoal, anti-helmintic, antituberculer, antispasmodic, antiasthmatic and antitussive, and analgesic and antipyretic. It also provides products for therapeutic areas in non-steroidal anti-inflammatory, steroi... [Read more]

Industry Pharmaceutical Preparations
Founded 1976
Employees 474
Stock Exchange Dhaka Stock Exchange
Ticker Symbol AMBEEPHA
Full Company Profile

Financial Performance

In fiscal year 2025, Ambee Pharmaceuticals's revenue was 230.55 million, an increase of 5.13% compared to the previous year's 219.30 million. Earnings were 5.31 million, a decrease of -45.17%.

Financial Statements

News

There is no news available yet.